Concepedia

Publication | Open Access

Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration

73

Citations

25

References

2015

Year

Abstract

Ranibizumab therapy for nAMD is associated with significant caregiver burden. Both disease impact and treatment frequency contributed to the overall burden.

References

YearCitations

Page 1